A two stage conditional power adaptive design adjusting for treatment by covariate interaction

Contemporary Clinical Trials

Volumn 29, Issue 3, 2008, Pages 428-438

  Ayanlowo, A O ^a   Redden, D T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adaptive design; Conditional power; Covariate by treatment interaction; Treatment effect

Indexed keywords

ANALYSIS OF COVARIANCE; ANALYTICAL ERROR; ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; METHODOLOGY; STATISTICAL SIGNIFICANCE; STATISTICS;

BIOMETRY; CLINICAL TRIALS AS TOPIC; MODELS, STATISTICAL; PROBABILITY; RESEARCH DESIGN; SAMPLE SIZE;

EID: 41949140575     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2007.10.003     Document Type: Article

References (18)

1. Ayanlowo A.O., and Redden D.T. Stochastically curtailed phase II clinical trial. Stat Med 26 (2007) 1462-1472
2. Lan K.K.G. Two stage design and sample size re-estimation. Presented at the Statistical Issues in Biopharmaceutical Environments conference (1996), De Montfort University, Leicester, U.K.
3. 0 embedded in sequential tests. Stat Med 16 (1997) 465-477
4. 0 based on conditional power: approximations and comparisons. Biometrics 53 (1997) 794-806
5. Lan K.K.G., Simon R., and Halperin M. Stochastically curtailed tests in long-term clinical trials. Commun Stat Seq Anal 1 (1982) 207-219
6. Pepe M.S., and Anderson G.L. Two-stage experimental designs: early stopping with a negative result. Appl Stat 41 (1992) 181-190
7. Proschan M.A., and Hunsberger S.A. Designed extension of studies based on conditional power. Biometrics 51 (1995) 1315-1324
8. Li G., Shih W.J., Xie T., and Lu J. A sample size adjustment procedure for clinical trials based on conditional power. Biostatistics 3 (2002) 277-287
9. Denne J. Sample size recalculation using conditional power. Stat Med 20 (2001) 2645-2660
10. Posch M., Bauer P., and Brannath W. Issues in designing flexible trials. Stat Med 22 (2003) 953-969
11. Jennison C., and Turnbull B.W. Mid-course sample size modification in clinical trials. Stat Med 22 (2003) 971-993
12. Cui L., Hung H.M.J., and Wang S. Modification of sample size in group sequential clinical trials. Biometrics 55 (1999) 321-324
13. Rosenberger W.F., Vidyashankar A.N., and Agarwal D.K. Covariate-adjusted response adaptive randomized designs for binary response. J Biopharm Stat 11 (2001) 227-236
14. Thall P.F., and Wathen J.K. Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments. Stat Med 24 (2005) 1947-1964
15. Breslow N.E., and Day N.E. Statistical methods in cancer research, Volume I: the analysis of case-control studies. Lyon, International Agency for Research on Cancer. IARC Scientific Publications 32 (1980) 5-338
16. Peto R. Statistical aspects of cancer trials. In: Halnan K.E. (Ed). Treatments of Cancer (1980), Chapman and Hall, London 867-871
17. R Development Core Team. R: A language and environment for statistical computing (2005), R Foundation for Statistical Computing, Vienna, Austria. 3-900051-07-0. http://http://www.R-project.org URL http://www.R-project.org
18. O'Brien R.G. A tour of UnifyPow: a SAS module/macro for sample-size analysis. Proceedings of the 23rd Annual SAS Users Group International Conference (1998), SAS Institute Inc., Cary NC 1346-1355